United States · 
Who invested in Zymosense?
Zymosense's investors include National Science Foundation.
United States · Venture startup
Who invested in Zymosense
Funding summaryUpdated 26 Oct 2026
Undisclosedraised across 1 round since 2022, from 1 source
- Latest round
- VentureJun 2022
- Investors
- 1
The rounds
- Jun 2022
Founders and team
From Zymosense's own website: 2 founders, 4 on the team.
Dr. Nathaniel KallmyerPhD, Co-Founder and CTO
Dr. Nigel ReuelPhD, Co-Founder and Chairman
- Scott D. NelsonCEO
- Jade SimsResearch Laboratory Manager
- Jon TempleResearch Specialist II
- Joseph McAuliffeIFF Technical Fellow and Sr Principal Scientist
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Zymosense
How much has Zymosense raised?
Zymosense has raised 1 round since 2022, none with a disclosed amount.
When did Zymosense last raise?
Zymosense's most recent round was a Venture in Jun 2022.
Who backed Zymosense first?
Zymosense's first round on record, in Jun 2022, was backed by National Science Foundation.
What stage is Zymosense at?
Zymosense's latest named round is a Venture, in Jun 2022.
Where is Zymosense based?
Zymosense is based in the United States.
Companies like Zymosense
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.